We're better off with mRNA vaccines
24 de feb. de 2021 ·
21m 47s
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
The technology that is helping us combat COVID-19 is also poised to help us tackle tough infectious and non-infectious diseases. Immunologist Sarah Fortune explains how these vaccines work, and how...
mostra más
The technology that is helping us combat COVID-19 is also poised to help us tackle tough infectious and non-infectious diseases. Immunologist Sarah Fortune explains how these vaccines work, and how the mRNA platform could transform the prevention and treatment of deadly diseases.In this episode of "Better Off," Harvard Chan School immunologist Sarah Fortune takes on common misconceptions about COVID-19 vaccines, and discusses the ways that mRNA technology could be used to create vaccines for diseases like TB and cancer.Guest: Sarah Fortune, John LaPorte Given Professor of Immunology and Infectious Diseases, Chair, Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public HealthFor a full transcript of this episode, visit our website. Subscribe to get new episodes of Better Off in your podcast feed every other Wednesday.Read more about Sarah Fortune's work, as well as the latest news from Harvard T.H. Chan School of Public Health at hsph.harvard.edu/news. Music in this episode:Ketsa – SabreBlue Dot Sessions – St. Augustine RedBlue Dot Sessions – Solear InterludeBlue Dot Sessions – Ewa Valley
mostra menos
Información
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
